| scholarly article | Q13442814 |
| P50 | author | Sandro Mazzaferro | Q40837703 |
| P2093 | author name string | Marzia Pasquali | |
| P2860 | cites work | Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia | Q24623628 |
| Does vitamin D sufficiency equate to a single serum 25-hydroxyvitamin D level or are different levels required for non-skeletal diseases? | Q26851499 | ||
| Structural considerations of vitamin D signaling | Q27022483 | ||
| Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway | Q27026805 | ||
| Klotho and phosphate are modulators of pathologic uremic cardiac remodeling | Q27342649 | ||
| Vitamin D deficiency | Q27860616 | ||
| Mitochondrial localization of vitamin D receptor in human platelets and differentiated megakaryocytes | Q28472571 | ||
| Regulation of the bone-specific osteocalcin gene by p300 requires Runx2/Cbfa1 and the vitamin D3 receptor but not p300 intrinsic histone acetyltransferase activity | Q28581756 | ||
| The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system | Q30426517 | ||
| Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient Data | Q30910917 | ||
| Evolution of matrix and bone gamma-carboxyglutamic acid proteins in vertebrates | Q33341094 | ||
| Novel bone endocrine networks integrating mineral and energy metabolism | Q33572134 | ||
| Rapid and genomic biological responses are mediated by different shapes of the agonist steroid hormone, 1alpha,25(OH)2vitamin D3. | Q33633435 | ||
| Vitamin D, intermediary metabolism and prostate cancer tumor progression | Q33647013 | ||
| FGF23 induces left ventricular hypertrophy | Q34028891 | ||
| Angiotensin receptors--evolutionary overview and perspectives | Q34117865 | ||
| A pooled analysis of vitamin D dose requirements for fracture prevention | Q34286007 | ||
| Vitamin D and subsequent all-age and premature mortality: a systematic review. | Q34863028 | ||
| Vitamin D3 regulates the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells | Q35238349 | ||
| New insights into Vitamin D sterol-VDR proteolysis, allostery, structure-function from the perspective of a conformational ensemble model | Q35868761 | ||
| The chicken or the egg: PHEX, FGF23 and SIBLINGs unscrambled | Q36074718 | ||
| Paralogous vitamin D receptors in teleosts: transition of nuclear receptor function | Q36578885 | ||
| From mitochondria to disease: role of the renin-angiotensin system | Q36929305 | ||
| Expression and regulation of the vitamin D receptor in the zebrafish, Danio rerio | Q36954020 | ||
| Vitamin D: calcium and bone homeostasis during evolution | Q37506713 | ||
| Bone as an endocrine organ. | Q37527342 | ||
| Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease | Q37781747 | ||
| Vitamin D: Evolutionary, Physiological and Health Perspectives | Q37783314 | ||
| Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms | Q37923110 | ||
| The contribution of bone to whole-organism physiology | Q37977006 | ||
| The skeleton as an endocrine organ | Q38050402 | ||
| Vitamin D receptor agonists specifically modulate the volume of the ligand-binding pocket | Q40316418 | ||
| Differing shapes of 1 alpha,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: a status report | Q40971139 | ||
| Functional characterization and purification of an intracellular vitamin D-binding protein in vitamin D-resistant new world primate cells. Amino acid sequence homology with proteins in the hsp-70 family | Q41120090 | ||
| Increased bone formation in osteocalcin-deficient mice. | Q41182577 | ||
| Cloning of a functional vitamin D receptor from the lamprey (Petromyzon marinus), an ancient vertebrate lacking a calcified skeleton and teeth | Q42441195 | ||
| 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells | Q42512729 | ||
| FGF23 regulates renal sodium handling and blood pressure | Q42952198 | ||
| Two Key Proteins of the Vitamin D Endocrine System Come Into Crystal Clear Focus: Comparison of the X‐ray Structures of the Nuclear Receptor for 1α,25(OH)2 Vitamin D3, the Plasma Vitamin D Binding Protein, and Their Ligands | Q44431642 | ||
| A perspective on how the Vitamin D sterol/Vitamin D receptor (VDR) conformational ensemble model can potentially be used to understand the structure-function results of A-ring modified Vitamin D sterols | Q46232092 | ||
| The development of CD-ring modified analogs of 1alpha,25-dihydroxyvitamin D. | Q49064790 | ||
| Excess 25-hydroxyvitamin D3 exacerbates tubulointerstitial injury in mice by modulating macrophage phenotype. | Q53425803 | ||
| Seawater chemistry and the advent of biocalcification | Q56626833 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | vitamin D | Q175621 |
| P304 | page(s) | 23-30 | |
| P577 | publication date | 2015-09-22 | |
| P1433 | published in | Nephrology Dialysis Transplantation | Q15710302 |
| P1476 | title | Vitamin D: a dynamic molecule. How relevant might the dynamism for a vitamin be? | |
| P478 | volume | 31 |
| Q38605841 | Calcifediol to Treat Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease. |
| Q49722254 | Current therapies in alleviating liver disorders and cancers with a special focus on the potential of vitamin D. |
| Q90330804 | Vitamin D and connective tissue diseases |
| Q47112383 | Vitamin D receptor is present on the neuronal plasma membrane and is co-localized with amyloid precursor protein, ADAM10 or Nicastrin. |
Search more.